Molecular Genetics tests in Dubai & UAE

Compare available Molecular Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Genetics test prices

Showing 1–15 of 18 matching tests.

Molecular Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4797 COL10A1 Gene Metaphyseal Chondrodysplasia, Schmid Type Genetic Test This genetic test analyzes the COL10A1 gene to detect pathogenic variants associated with metaphyseal chondrodysplasia Schmid type.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL10A1 gene"] Parameters [] Preparation ["No specific fasting required", "Do not alter or discontinue prescribed medications without consulting your physician"] Indications ["Clinical or radiological suspicion of metaphyseal chondrodysplasia Schmid type", "Family history of skeletal dysplasia"] Measurement technique Confirm with laboratory Codes LOINC: 101651-1 ICD-10: Q78.5, Z13.79, Z15.89 Clinical summary This genetic test analyzes the COL10A1 gene to detect pathogenic variants associated with metaphyseal chondrodysplasia Schmid type.
TEST-1896 CYLD Gene (Multiple Familial Trichoepithelioma Type 1) Genetic Test This test evaluates the CYLD gene for pathogenic mutations associated with multiple familial trichoepithelioma type 1.	Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYLD gene mutations", "Copy Number Variations (CNVs) in CYLD gene"] Parameters [] Preparation ["Pre-test genetic counseling session required", "Three-generation pedigree chart must be completed"] Indications ["Suspected diagnosis of multiple familial trichoepithelioma type 1", "Family history of the condition", "Genetic counseling for hereditary skin tumor syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 93792-9 ICD-10: Q82.8, Z15.09, Z84.81 Clinical summary This test evaluates the CYLD gene for pathogenic mutations associated with multiple familial trichoepithelioma type 1.
TEST-5190 DKC1 Gene Dyskeratosis Congenita, X-Linked Genetic Test This genetic test identifies pathogenic variants in the DKC1 gene associated with X-linked dyskeratosis congenita.	Peripheral whole blood (3–5 mL) in EDTA tube; Dried Blood Spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DKC1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Deep intronic variants", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Genetic counseling session mandatory prior to sample collection"] Indications ["Suspected X-linked dyskeratosis congenita", "Inherited bone marrow failure syndromes", "Family history of early-onset cancers linked to telomere biology disorders", "Female carriers considering pregnancy"] Measurement technique Confirm with laboratory Codes LOINC: 21603-0 ICD-10: D61.0 Clinical summary This genetic test identifies pathogenic variants in the DKC1 gene associated with X-linked dyskeratosis congenita.
TEST-5871 GPR161 Gene Pituitary Stalk Interruption Syndrome (GPR161-Related) Genetic Test This genetic test analyzes the GPR161 gene to detect variants associated with pituitary stalk interruption syndrome.	Peripheral Whole Blood (3–5 mL in EDTA tube), Extracted DNA (≥1 µg), or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GPR161 gene sequence", "Pathogenic variants in GPR161"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions"] Indications ["Suspected pituitary stalk interruption syndrome", "Multiple pituitary hormone deficiencies", "Family history of PSIS"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E23.0, Q04.4 Clinical summary This genetic test analyzes the GPR161 gene to detect variants associated with pituitary stalk interruption syndrome.
TEST-4780 IDH1 Gene Genetic Test for Metaphyseal Chondromatosis with D-2-Hydroxyglutaric Aciduria This test evaluates the IDH1 gene for pathogenic variants associated with metaphyseal chondromatosis and D-2-hydroxyglutaric aciduria.	Peripheral Whole Blood (EDTA), Buccal Swab, or Pre-Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH1 gene pathogenic variants", "Skeletal dysplasia genetic markers"] Parameters [] Preparation [] Indications ["Characteristic skeletal anomalies", "Unexplained elevation of urinary D-2-hydroxyglutarate", "Positive family history suggestive of autosomal dominant skeletal dysplasia"] Measurement technique Confirm with laboratory Codes LOINC: 92769-6 ICD-10: Q78.8, E72.5 Clinical summary This test evaluates the IDH1 gene for pathogenic variants associated with metaphyseal chondromatosis and D-2-hydroxyglutaric aciduria.
TEST-5101 KRT1 Gene Epidermolytic Hyperkeratosis (EHK) Genetic Test This genetic test identifies pathogenic mutations in the KRT1 gene, confirming a diagnosis of epidermolytic hyperkeratosis (EHK).	Whole Blood, FTA Card, Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the KRT1 gene"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory", "Provide a detailed family pedigree spanning at least three generations"] Indications ["Suspected epidermolytic hyperkeratosis (EHK)", "Differentiation from other ichthyosis subtypes", "Genetic counseling", "Prenatal screening"] Measurement technique Confirm with laboratory Codes LOINC: 90356-4 ICD-10: Q80.3 Clinical summary This genetic test identifies pathogenic mutations in the KRT1 gene, confirming a diagnosis of epidermolytic hyperkeratosis (EHK).
TEST-5942 Mucopolysaccharidosis Type II (MPS II) IDS Gene Genetic Test This test analyzes the IDS gene to detect pathogenic variants associated with Mucopolysaccharidosis Type II (Hunter syndrome). It provides a definitive molecular diagnosis for this...	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IDS gene", "Copy number variations (deletions/duplications) in the IDS gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of suspected Hunter syndrome", "Carrier screening for family members", "Prenatal diagnosis", "Preimplantation genetic diagnosis (PGD)"] Measurement technique Confirm with laboratory Codes LOINC: 82850-2 ICD-10: E76.1 Clinical summary This test analyzes the IDS gene to detect pathogenic variants associated with Mucopolysaccharidosis Type II (Hunter syndrome). It provides a definitive molecular diagnosis for this X-linked lysosomal storage disorder.
TEST-5490 NDP Gene Norrie Disease Genetic Test This test identifies pathogenic mutations within the NDP gene, confirming a diagnosis of Norrie disease.	Whole Blood (Peripheral Venous Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDP gene mutations", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Individuals with clinical suspicion of Norrie disease", "Families with a known NDP mutation for carrier testing and prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 51952-3 ICD-10: Q15.8 Clinical summary This test identifies pathogenic mutations within the NDP gene, confirming a diagnosis of Norrie disease.
TEST-5981 OGDH Gene Alpha‑Ketoglutarate Dehydrogenase Deficiency Genetic Test This genetic test evaluates the OGDH gene for mutations associated with alpha-ketoglutarate dehydrogenase deficiency, an inborn error of metabolism.	Peripheral whole blood (EDTA)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["OGDH gene coding region", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection", "Submit a completed three-generation pedigree chart"] Indications ["Diagnostic confirmation of alpha-ketoglutarate dehydrogenase deficiency", "Carrier screening", "Family risk assessment", "Confirmed family history of metabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 79324-3 ICD-10: E88.8, G31.8, Z13.79 Clinical summary This genetic test evaluates the OGDH gene for mutations associated with alpha-ketoglutarate dehydrogenase deficiency, an inborn error of metabolism.
TEST-4072 SERPING1 Gene Hereditary Angioedema Genetic Test This test identifies pathogenic mutations within the SERPING1 gene, confirming a diagnosis of hereditary angioedema types I and II.	Peripheral whole blood (3–5 mL in EDTA tube) or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SERPING1 gene sequence", "Pathogenic mutations in SERPING1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected hereditary angioedema (HAE) types I or II", "Family history of HAE", "Need for definitive diagnosis for treatment planning", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 82753-8 ICD-10: D84.1 Clinical summary This test identifies pathogenic mutations within the SERPING1 gene, confirming a diagnosis of hereditary angioedema types I and II.
TEST-4817 SGCG Gene LGMD2C Genetic Test This test analyzes the SGCG gene to detect mutations associated with Limb-Girdle Muscular Dystrophy Type 2C (LGMD2C). It identifies various types of genetic alterations, including...	Peripheral Whole Blood (EDTA) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SGCG gene coding region", "SGCG gene adjacent splice sites", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number alterations (CNAs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Clinical suspicion of Limb-Girdle Muscular Dystrophy Type 2C (LGMD2C)", "Family history of LGMD2C", "Need for definitive genetic diagnosis for prognosis and management", "Genetic counseling and cascade testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.09 Clinical summary This test analyzes the SGCG gene to detect mutations associated with Limb-Girdle Muscular Dystrophy Type 2C (LGMD2C). It identifies various types of genetic alterations, including single nucleotide variants, insertions, deletions, and copy number changes.
TEST-3693 SLC22A12 Gene (Renal Hypouricemia Type 1) Genetic Test This genetic test identifies pathogenic variants in the SLC22A12 gene associated with renal hypouricemia type 1.	Whole blood (EDTA) or FTA card blood spot	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC22A12 gene sequence", "Pathogenic variants in URAT1 transporter gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Diagnosis of renal hypouricemia type 1", "Assessment of risk for exercise-induced kidney injury", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 101299-0 ICD-10: E79.0 Clinical summary This genetic test identifies pathogenic variants in the SLC22A12 gene associated with renal hypouricemia type 1.
TEST-4018 SLC6A2 Gene Orthostatic Intolerance Genetic Test This test analyzes the SLC6A2 gene for variants associated with orthostatic intolerance and autonomic dysfunction.	Whole blood (EDTA tube) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC6A2 gene sequence", "Norepinephrine transporter function"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all current medications"] Indications ["Suspected POTS", "Suspected neurogenic orthostatic hypotension", "Family history of orthostatic intolerance"] Measurement technique Confirm with laboratory Codes LOINC: 81321-4 ICD-10: I95.1, G90.9 Clinical summary This test analyzes the SLC6A2 gene for variants associated with orthostatic intolerance and autonomic dysfunction.
TEST-2525 SMAD4 Gene Myhre Syndrome Genetic Test This test analyzes the entire SMAD4 gene using Next-Generation Sequencing (NGS) to detect pathogenic variants associated with Myhre syndrome.	Peripheral Whole Blood (EDTA) or Derived DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMAD4 gene", "Full gene coverage including intronic and splice-site regions"] Parameters [] Preparation [] Indications ["Children presenting with features suggestive of Myhre syndrome", "Individuals with a family history of Myhre syndrome", "Atypical connective tissue disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test analyzes the entire SMAD4 gene using Next-Generation Sequencing (NGS) to detect pathogenic variants associated with Myhre syndrome.
TEST-4291 ST3GAL3 Gene (Early Infantile Epileptic Encephalopathy Type 15) Genetic Test This genetic test evaluates the ST3GAL3 gene for mutations associated with early infantile epileptic encephalopathy type 15 (EIEE15). It identifies variants like SNVs, indels, and...	Peripheral Whole Blood (EDTA) or Buccal Swab	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ST3GAL3 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "Splice-site variants"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Detailed clinical history, prior EEG reports, and neuroimaging results needed for pre-test counselling"] Indications ["Diagnosis of EIEE15", "Identification of ST3GAL3 gene mutations", "Guiding targeted therapeutic decisions", "Prognostic counselling", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.4 Clinical summary This genetic test evaluates the ST3GAL3 gene for mutations associated with early infantile epileptic encephalopathy type 15 (EIEE15). It identifies variants like SNVs, indels, and CNVs.

Category overview

Molecular Genetics: overview

Achieving a definitive diagnosis for complex, inherited conditions requires looking at the very foundation of your biological code. As the cornerstone of our advanced laboratory services, the Molecular Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare diseases, inherited cancers, and complex metabolic disorders. By leveraging cutting-edge molecular technology, this expansive profiling helps establish an absolute diagnosis, safely guiding your healthcare provider in tailoring highly personalized precision medicine, targeted therapies, and specialized reproductive counseling. Consistently ranked among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, uncompromising diagnostic accuracy, and highly efficient turnaround times. Prioritize your personalized healthcare journey—schedule your molecular genetics testing in UAE, coordinate a seamless home sample collection, or consult our expert medical genetics team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.